Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dehydroascorbic acid transmembrane transporter activity	SLC2A14 SLC2A1 SLC2A3	3.12e-05	8	167	3	GO:0033300
GeneOntologyMolecularFunction	hexose transmembrane transporter activity	SLC5A10 SLC2A14 SLC2A1 SLC2A3	5.20e-05	25	167	4	GO:0015149
GeneOntologyMolecularFunction	D-glucose transmembrane transporter activity	SLC5A10 SLC2A14 SLC2A1 SLC2A3	5.20e-05	25	167	4	GO:0055056
GeneOntologyMolecularFunction	xylose binding	SLC2A14 SLC2A3	6.95e-05	2	167	2	GO:0033222
GeneOntologyMolecularFunction	monosaccharide transmembrane transporter activity	SLC5A10 SLC2A14 SLC2A1 SLC2A3	7.13e-05	27	167	4	GO:0015145
GeneOntologyMolecularFunction	sugar transmembrane transporter activity	SLC5A10 SLC2A14 SLC2A1 SLC2A3	9.52e-05	29	167	4	GO:0051119
GeneOntologyMolecularFunction	carbohydrate transmembrane transporter activity	SLC5A10 SLC2A14 SLC2A1 SLC2A3	4.12e-04	42	167	4	GO:0015144
Domain	Glc_transpt_3	SLC2A14 SLC2A3	8.04e-05	2	168	2	IPR002945
Domain	A1A_glycop	ORM1 ORM2	8.04e-05	2	168	2	IPR001500
Domain	Ephrin_rec_like	EPHB6 SVEP1 TG	1.12e-04	11	168	3	PF07699
Domain	Sugar/inositol_transpt	SLC2A14 SLC2A1 SLC2A3	2.42e-04	14	168	3	IPR003663
Domain	uDENN	DENND1C SBF1 DENND5A	2.42e-04	14	168	3	SM00800
Domain	uDENN	DENND1C SBF1 DENND5A	3.00e-04	15	168	3	PF03456
Domain	DENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	SM00799
Domain	DENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	PF02141
Domain	dDENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	PF03455
Domain	UDENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	PS50946
Domain	DDENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	PS50947
Domain	dDENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	SM00801
Domain	dDENN_dom	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	IPR005112
Domain	uDENN_dom	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	IPR005113
Domain	DENN	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	PS50211
Domain	DENN_dom	DENND1C SBF1 DENND5A	3.67e-04	16	168	3	IPR001194
Domain	SUGAR_TRANSPORT_2	SLC2A14 SLC2A1 SLC2A3	4.43e-04	17	168	3	PS00217
Domain	ABHD4	ABHD15 ABHD1	4.77e-04	4	168	2	IPR012020
Domain	C1-set_C	HLA-DQA1 HLA-DRA	7.90e-04	5	168	2	PF16196
Domain	MHC_II_alpha	HLA-DQA1 HLA-DRA	7.90e-04	5	168	2	SM00920
Domain	C1-set_C	HLA-DQA1 HLA-DRA	7.90e-04	5	168	2	IPR032431
Pathway	REACTOME_CELLULAR_HEXOSE_TRANSPORT	SLC5A10 SLC2A14 SLC2A1 SLC2A3	1.53e-05	19	116	4	MM14718
Pathway	REACTOME_CELLULAR_HEXOSE_TRANSPORT	SLC5A10 SLC2A14 SLC2A1 SLC2A3	2.34e-05	21	116	4	M27058
Pathway	REACTOME_VITAMIN_C_ASCORBATE_METABOLISM	SLC2A14 SLC2A1 SLC2A3	4.40e-05	9	116	3	MM14769
Pathway	BIOCARTA_VITCB_PATHWAY	SLC2A14 SLC2A1 SLC2A3	1.13e-04	12	116	3	MM1526
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TMEM94 NAGLU MED14 WRAP53 SRCAP MBD6 ADGRA2 SLC2A1 TBC1D24 PIKFYVE DIP2A INTS5 TNRC18 RPAP1 ZBED4 SBF1 NBEAL2 CSPG4 CPSF1 MAP3K11 CACNA1H DENND5A HERC1 HCFC1	1.51e-09	1105	173	24	35748872
Pubmed	Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	9108057
Pubmed	Significant reduction of the GLUT3 level, but not GLUT1 level, was observed in the brain tissues of several scrapie experimental animals and scrapie-infected cell lines.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	24243341
Pubmed	Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	1730609
Pubmed	Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	17213475
Pubmed	Gestational changes of glucose transporter gene expression in the mouse placenta and decidua.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	8905482
Pubmed	Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer's Disease Model Mice.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	31561359
Pubmed	Hyperglycemia reduces mitochondrial content and glucose transporter expression in mouse embryos developing in vitro.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	19550108
Pubmed	Placental glucose transporter expression is regulated by glucocorticoids.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	10199793
Pubmed	Glucose transporter proteins in brain.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	7926364
Pubmed	Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	30765335
Pubmed	Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	3170580
Pubmed	Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	19327547
Pubmed	Deletion of GLUT1 and GLUT3 Reveals Multiple Roles for Glucose Metabolism in Platelet and Megakaryocyte Function.	SLC2A14 SLC2A1 SLC2A3	1.21e-07	3	173	3	28746873
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	C12orf56 TUT7 RGS3 RFWD3 POLR3A DIP2A LLGL1 RPAP1 SBF1 RECQL4 NEMF NFXL1 YY1AP1 DENND5A HCFC1 LRRC41	1.85e-07	650	173	16	38777146
Pubmed	A Nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendoderm differentiation of embryonic stem cells.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	35810171
Pubmed	Glucose utilization and glucose transporter proteins GLUT-1 and GLUT-3 in brains of diabetic (db/db) mice.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	9124334
Pubmed	Oxygen-regulated expression of GLUT-1, GLUT-3, and VEGF in the mouse blastocyst.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	15515055
Pubmed	Hypoxia regulation of facilitated glucose transporter-1 and glucose transporter-3 in mouse chondrocytes mediated by HIF-1alpha.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	17983831
Pubmed	Prenatal Exposure to Sodium Arsenite Alters Placental Glucose 1, 3, and 4 Transporters in Balb/c Mice.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	26339590
Pubmed	Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	8557327
Pubmed	GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	37721853
Pubmed	Glucose uptake, utilization, and signaling in GLUT2-null islets.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	10969832
Pubmed	Immunohistochemical localization and quantification of glucose transporters in the mouse brain.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	11955709
Pubmed	Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	34035344
Pubmed	Glucose transporter expression and functional role of hexokinase in insulin biosynthesis in mouse beta TC3 cells.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	7653530
Pubmed	Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	9688872
Pubmed	Developmental regulation of genes mediating murine brain glucose uptake.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	10070152
Pubmed	In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.	SLC2A14 SLC2A1 SLC2A3	4.82e-07	4	173	3	10455018
Pubmed	Prenatal expression of the GLUT4 glucose transporter in the mouse.	SLC2A14 SLC2A1 SLC2A3	1.20e-06	5	173	3	10965149
Pubmed	GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.	SLC2A14 SLC2A1 SLC2A3	1.20e-06	5	173	3	33753374
Pubmed	Differential screening of a PCR-generated mouse embryo cDNA library: glucose transporters are differentially expressed in early postimplantation mouse embryos.	SLC2A14 SLC2A1 SLC2A3	1.20e-06	5	173	3	1289053
Pubmed	Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development.	SLC2A14 SLC2A1 SLC2A3	1.20e-06	5	173	3	1638987
Pubmed	The glucose transporter family: structure, function and tissue-specific expression.	SLC2A14 SLC2A1 SLC2A3	1.20e-06	5	173	3	8240230
Pubmed	Molecular identification and functional characterization of the vitamin C transporters expressed by Sertoli cells.	SLC2A14 SLC2A1 SLC2A3	2.39e-06	6	173	3	18668520
Pubmed	Metabolic mode peculiar to Meckel's cartilage: immunohistochemical comparisons of hypoxia-inducible factor-1alpha and glucose transporters in developing endochondral bones in mice.	SLC2A14 SLC2A1 SLC2A3	2.39e-06	6	173	3	18705802
Pubmed	Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.	SLC2A14 SLC2A1 SLC2A3	2.39e-06	6	173	3	32571479
Pubmed	Glucose uptake mediated by glucose transporter 1 is essential for early tooth morphogenesis and size determination of murine molars.	SLC2A14 SLC2A1 SLC2A3	2.39e-06	6	173	3	22226978
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	DHX8 RIF1 ZBED4 ARIH2 MED25 SMARCC2 HCFC1	4.00e-06	129	173	7	23022380
Pubmed	Essential role of glucose transporter GLUT3 for post-implantation embryonic development.	SLC2A14 SLC2A1 SLC2A3	4.17e-06	7	173	3	18948350
Pubmed	TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation.	TG ORM1 ORM2	4.17e-06	7	173	3	9214635
Pubmed	Large-scale concatenation cDNA sequencing.	TMEM94 SLC44A2 MED14 ADCK2 RGS3 SLC2A1 RIF1 NT5DC2 AOC3 MED25 CACNA1H HERC1 DKK3	5.98e-06	568	173	13	9110174
Pubmed	Assignment of 12 loci to rat chromosome 5: evidence that this chromosome is homologous to mouse chromosome 4 and to human chromosomes 9 and 1 (1p arm).	SLC2A1 ORM1 ORM2	6.65e-06	8	173	3	2341157
Pubmed	Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice.	SLC2A14 SLC2A1 SLC2A3	9.94e-06	9	173	3	18845627
Pubmed	GLUT1 is redundant in hypoxic and glycolytic nucleus pulposus cells of the intervertebral disc.	SLC2A14 SLC2A1 SLC2A3	9.94e-06	9	173	3	36917198
Pubmed	Mapping of PCR-based markers for mouse chromosome 4 on a backcross penetrant for the misty (m) mutation.	SLC2A1 ORM1 ORM2	1.41e-05	10	173	3	7949731
Pubmed	Prolonged endoplasmic reticulum stress alters placental morphology and causes low birth weight.	SLC2A14 SLC2A1 SLC2A3	1.41e-05	10	173	3	24370435
Pubmed	Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor.	ADGRA2 SLC2A1 CSPG4	1.41e-05	10	173	3	21282641
Pubmed	Osteoblast-specific expression of Panx3 is dispensable for postnatal bone remodeling.	CA9 SLC2A14 SLC2A1 SLC2A3 RHBDL2 SLC13A1	1.75e-05	108	173	6	31202927
Pubmed	Neural Deletion of Glucose Transporter Isoform 3 Creates Distinct Postnatal and Adult Neurobehavioral Phenotypes.	SLC2A14 SLC2A1 SLC2A3	1.94e-05	11	173	3	30232223
Pubmed	The rat gene map.	TG ORM1 ORM2	1.94e-05	11	173	3	3416641
Pubmed	A pair of co-opted retroviral envelope syncytin genes is required for formation of the two-layered murine placental syncytiotrophoblast.	GJB6 SLC2A14 SLC2A3	1.94e-05	11	173	3	22032925
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	CA9 HGFAC MYADM SLC2A14 TMPRSS4 SLC2A3 FCRL1 OLFML1 NBEAL2 DKK3 ACSL5	2.12e-05	460	173	11	20562862
Pubmed	Defining the membrane proteome of NK cells.	IGSF8 MYO1G ABHD15 HLA-DQA1 MARS1 POLD1 MED14 TMBIM6 POLR3A INTS5 NBEAL2 RECQL4 NFXL1 MAP3K11 ALG6 HCFC1 ACSL5 LRRC41	2.32e-05	1168	173	18	19946888
Pubmed	Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.	ORM1 ORM2	2.46e-05	2	173	2	24389491
Pubmed	Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics.	SLC2A14 SLC2A3	2.46e-05	2	173	2	23615220
Pubmed	A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.	ORM1 ORM2	2.46e-05	2	173	2	15253437
Pubmed	SUMOylation regulates USP5-Cav3.2 calcium channel interactions.	USP5 CACNA1H	2.46e-05	2	173	2	31455361
Pubmed	Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.	ORM1 ORM2	2.46e-05	2	173	2	16290938
Pubmed	Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.	SLC2A14 SLC2A1	2.46e-05	2	173	2	26183839
Pubmed	Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.	SLC2A1 SLC2A3	2.46e-05	2	173	2	22270867
Pubmed	Retinoids increase alpha-1 acid glycoprotein expression at the transcriptional level through two distinct DR1 retinoic acid responsive elements.	ORM1 ORM2	2.46e-05	2	173	2	15157739
Pubmed	Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis.	ORM1 ORM2	2.46e-05	2	173	2	37949310
Pubmed	Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF.	ORM1 ORM2	2.46e-05	2	173	2	17987628
Pubmed	α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages.	ORM1 ORM2	2.46e-05	2	173	2	34210751
Pubmed	Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.	ORM1 ORM2	2.46e-05	2	173	2	37640741
Pubmed	An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.	ORM1 ORM2	2.46e-05	2	173	2	33846468
Pubmed	Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.	ORM1 ORM2	2.46e-05	2	173	2	28927749
Pubmed	A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.	USP5 CACNA1H	2.46e-05	2	173	2	27130589
Pubmed	Immunolocalization of glucose transporter 1 and 3 in the placenta: application to cytodiagnosis of Papanicolaou smear.	SLC2A1 SLC2A3	2.46e-05	2	173	2	12112827
Pubmed	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.	SLC2A14 SLC2A3	2.46e-05	2	173	2	25892112
Pubmed	CD205+ polymorphonuclear myeloid-derived suppressor cells suppress antitumor immunity by overexpressing GLUT3.	SLC2A14 SLC2A3	2.46e-05	2	173	2	33368883
Pubmed	α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice.	ORM1 ORM2	2.46e-05	2	173	2	22415874
Pubmed	Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins.	ORM1 ORM2	2.46e-05	2	173	2	4711474
Pubmed	Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents.	SLC2A1 SLC2A3	2.46e-05	2	173	2	33402433
Pubmed	Structure and expression of the genes coding for human alpha 1-acid glycoprotein.	ORM1 ORM2	2.46e-05	2	173	2	2822385
Pubmed	Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.	ORM1 ORM2	2.46e-05	2	173	2	20442402
Pubmed	Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.	ORM1 ORM2	2.46e-05	2	173	2	25264156
Pubmed	Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes.	SLC2A1 SLC2A3	2.46e-05	2	173	2	10862609
Pubmed	GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma.	SLC2A1 SLC2A3	2.46e-05	2	173	2	20428049
Pubmed	Molecular characterization and acute phase expression of the multiple Mus caroli alpha 1-acid glycoprotein (AGP) genes. Differences in glucocorticoid stimulation and regulatory elements between the rat and mouse AGP genes.	ORM1 ORM2	2.46e-05	2	173	2	2354997
Pubmed	Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice.	SLC2A14 SLC2A3	2.46e-05	2	173	2	18780771
Pubmed	Diagnostic value of metabolic phenotypes in malignant pleural effusions: expression of GLUT1 and CAIX by immunocytochemistry.	CA9 SLC2A1	2.46e-05	2	173	2	21442770
Pubmed	Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.	SLC2A1 SLC2A3	2.46e-05	2	173	2	18401196
Pubmed	Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.	NCAN CSPG4	2.46e-05	2	173	2	22628090
Pubmed	Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients.	ORM1 ORM2	2.46e-05	2	173	2	25408356
Pubmed	Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1.	ORM1 ORM2	2.46e-05	2	173	2	3676251
Pubmed	Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene.	ORM1 ORM2	2.46e-05	2	173	2	2970990
Pubmed	The disulfide bonds of alpha1-acid glycoprotein.	ORM1 ORM2	2.46e-05	2	173	2	4603214
Pubmed	Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain.	SLC2A14 SLC2A3	2.46e-05	2	173	2	1734877
Pubmed	Sevoflurane Induces Learning and Memory Impairment in Young Mice Through a Reduction in Neuronal Glucose Transporter 3.	SLC2A14 SLC2A3	2.46e-05	2	173	2	31884568
Pubmed	Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation.	ORM1 ORM2	2.46e-05	2	173	2	37853937
Pubmed	Temporal and spatial distribution of murine placental and brain GLUT3-luciferase transgene as a readout of in vivo transcription.	SLC2A14 SLC2A3	2.46e-05	2	173	2	23193055
Pubmed	Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos.	SLC2A14 SLC2A3	2.46e-05	2	173	2	8198523
Pubmed	A mouse gene family associated with a major submaxillary-gland glycoprotein.	ORM1 ORM2	2.46e-05	2	173	2	3977853
Pubmed	Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3).	ORM1 ORM2	2.46e-05	2	173	2	1605854
Pubmed	Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase δ catalytic subunit gene, POLD1.	POLD1 PRMT7	2.46e-05	2	173	2	22761421
Pubmed	Glucose transporter (Glut1, Glut3) mRNA in human placenta of diabetic and non-diabetic pregnancies.	SLC2A1 SLC2A3	2.46e-05	2	173	2	10086067
Pubmed	Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide.	SLC2A1 SLC2A3	2.46e-05	2	173	2	28631569
Pubmed	Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression.	SLC2A14 SLC2A3	2.46e-05	2	173	2	29582588
GeneFamily	WD repeat domain containing	NWD1 WRAP53 WDFY4 RFWD3 WDR93 LLGL1 NBEAL2 HERC1	3.63e-04	262	120	8	362
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND1C SBF1 DENND5A	5.89e-04	25	120	3	504
ToppCell	remission-B_intermediate\|World / disease stage, cell group and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C DOP1B	4.60e-09	194	172	10	78556b60c84c7bbffa1c8bf8684b3c427512da44
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 MED25 TNFRSF13C	4.83e-09	195	172	10	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 MED25 TNFRSF13C	4.83e-09	195	172	10	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	severe-B_memory\|severe / disease stage, cell group and cell class	TAS1R3 HLA-DQA1 HLA-DRA LGR4 NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	2.56e-08	173	172	9	3a987ac53a0136cc4c70ce8b901a15fc00c795e1
ToppCell	severe-B_memory\|World / disease stage, cell group and cell class	TAS1R3 HLA-DQA1 HLA-DRA LGR4 NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	2.97e-08	176	172	9	4e5c6b1aa5ffd13593a6bcd1e1253c1737c5c2b4
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAS1R3 HLA-DQA1 PCDHB7 NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	4.15e-08	183	172	9	82fe14fc7039415de41bdfd615a1380bed99f560
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	KLHL6 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	5.00e-08	187	172	9	af1327559f7e01bec070881cae52834917c3da65
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	5.24e-08	188	172	9	18d16e3f095a109b6a690f46fe7fcd5674c3636b
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	KLHL6 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	5.74e-08	190	172	9	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTCRA HLA-DQA1 HLA-DRA IRF7 NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	6.56e-08	193	172	9	325859399411d0e66a78a385dffa886df9af3198
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.56e-08	193	172	9	94b5a4a4e9faaa95cb72907a2f0497429c72e516
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.56e-08	193	172	9	437ae3b10d169bb371f7b92d57a77f43e3f8d64d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.56e-08	193	172	9	2416b39e18ce0c7016c2351f79bf1b2ecc183a98
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 MED25 TNFRSF13C	6.86e-08	194	172	9	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.86e-08	194	172	9	2b5eee7c3e52b63cce94205d18133c7704329c02
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTCRA HLA-DQA1 HLA-DRA IRF7 NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	7.16e-08	195	172	9	0bd26c2f14bddff94ac25638c0b12c95c8a4d468
ToppCell	5'-Adult-LymphNode-Hematopoietic-B_cells-Naive_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 HLA-DRA SLC44A2 NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	7.16e-08	195	172	9	630bfe5b192d247bab7cf8bc5a0780c7f8d67501
ToppCell	COVID-19_Convalescent-Lymphoid_B-B_intermediate\|COVID-19_Convalescent / Disease group, lineage and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.16e-08	195	172	9	b213f19dad4c8d5a6bf20cadb1135fb2bb0b40ee
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTCRA HLA-DQA1 HLA-DRA IRF7 NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	7.16e-08	195	172	9	d4101fcb1fba44c778b088544392c32b5d7c4793
ToppCell	remission-B_intermediate\|remission / disease stage, cell group and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.16e-08	195	172	9	ee14d00eb5800fadd57c2304e9461534d8668674
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KLHL6 TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	7.82e-08	197	172	9	e4b4fa219322b3250b482f8e242f41e8b05485db
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KLHL6 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	8.16e-08	198	172	9	863765ccc0205dc28864dae85af339c283194c96
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_intermediate\|COVID-19_Convalescent / Disease, condition lineage and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.89e-08	200	172	9	fdc0df661a34e0db3279334bdeebfdf60c85ef41
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO1G HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	8.89e-08	200	172	9	4f7be296be0cd54cfc62cc93263fde26210c61f4
ToppCell	Mild/Remission-B_naive-4\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-DQA1 HLA-DRA NIBAN3 ADAM28 USF3 FCRL1 TNFRSF13C CACNA1H	1.16e-07	148	172	8	dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	2.43e-07	163	172	8	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	3.83e-07	173	172	8	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAS1R3 HLA-DQA1 HLA-DRA MED14 NIBAN3 ADAM28 TNFRSF13C ABHD1	4.00e-07	174	172	8	59ccc5a82507463e0a316ba6286cb25ec1a4091b
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL6 NWD1 DBX2 GJB6 LGR4 ORM2 NCAN DKK3	4.36e-07	176	172	8	ac3dc44755280e36c0947b6de3cd639dc17de8b6
ToppCell	COVID-19_Moderate-B_intermediate\|COVID-19_Moderate / disease group, cell group and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	4.56e-07	177	172	8	68e3d12a0c048a2d0f1b9680c7338a35855bba30
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KLHL6 PTCRA HLA-DQA1 HLA-DRA IRF7 NIBAN3 WDFY4 ADAM28	4.56e-07	177	172	8	c5e829bc4594761666d65cace5a9c5d19c16f187
ToppCell	COVID-19-kidney-Bcells\|kidney / Disease (COVID-19 only), tissue and cell type	KLHL6 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	5.17e-07	180	172	8	5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b
ToppCell	10x5'-Liver-Lymphocytic_B-Memory_B_cells\|Liver / Manually curated celltypes from each tissue	KLHL6 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	5.40e-07	181	172	8	a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DQA1 HLA-DRA NIBAN3 ADAM28 SLC2A3 PIKFYVE FCRL1 TNFRSF13C	5.40e-07	181	172	8	d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCell	wk_08-11-Hematologic-Myeloid-pre-pDC/DC5\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KLHL6 HLA-DQA1 HLA-DRA ACP3 IRF7 NIBAN3 WDFY4 ACSL5	5.63e-07	182	172	8	fec8a2d6d4099722b8e1bb41222108ed74268fcf
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 OLFML1 TNFRSF13C	5.86e-07	183	172	8	be294d22b91dbcf1e8d22e6a31c39b5caaad4751
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.63e-07	186	172	8	d7d884ff4184636081c350d29f797bd923c6a3b4
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	6.63e-07	186	172	8	b5e094850ac3785775393cd78a939b02339732b0
ToppCell	lymphoid-B_cell-Naive_B_cell\|World / Lineage, cell class and subclass	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.91e-07	187	172	8	904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3
ToppCell	(1)_B_CD27pos\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	MYO1G HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 TNFRSF13C	6.91e-07	187	172	8	bb189942123eb03dd6505f1af8771dd7285bb8b9
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.91e-07	187	172	8	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	6.91e-07	187	172	8	57ea69f777420f0671b131c97bcce71d77e29286
ToppCell	lymphoid-B_cell\|World / Lineage, cell class and subclass	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	6.91e-07	187	172	8	2abbc01fd7f5b4e52113699625287893c991f8da
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	7.19e-07	188	172	8	6f53bcd4caab2fc961af799039ea5c3ddae56781
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	7.19e-07	188	172	8	d1bc1316bbb8cfc39acc70f8680b14d19f536997
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAS1R3 HLA-DQA1 HLA-DRA WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.48e-07	189	172	8	2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	7.48e-07	189	172	8	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	COVID_vent-Lymphocytic-B_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.79e-07	190	172	8	40b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCell	COVID_vent-Lymphocytic-B_cell-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.79e-07	190	172	8	a37a32dc1b931562a6660074e19d5598efc65284
ToppCell	lymphoid-B_cell-Naive_B_cell\|lymphoid / Lineage, cell class and subclass	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.79e-07	190	172	8	b8b05894e811e431d797ac4fa3ccff4963a154e7
ToppCell	COVID-19_Severe-Lymphoid_B-B_memory\|COVID-19_Severe / Disease group, lineage and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	7.79e-07	190	172	8	b6510c419a15ed049c0a0a6a6697b643668741c3
ToppCell	lymphoid-B_cell\|lymphoid / Lineage, cell class and subclass	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	7.79e-07	190	172	8	c451de643ee08c2ff1093e807c65d724237473c5
ToppCell	BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ABHD15 PTCRA HLA-DQA1 IRF7 NIBAN3 WDFY4 ADAM28 SLC2A1	7.79e-07	190	172	8	9b8de47f7a2e6137d934ccce32417ab15eb54f46
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DQA1 HLA-DRA LGR4 NIBAN3 ADAM28 FCRL1 TNFRSF13C	7.91e-07	131	172	7	d76a7a9b50ee6d24b74494c6f6b88b3506b3f9ad
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK PCDHB2 SVEP1 WDR93 CSPG4 AOC3 TENM1 DKK3	8.10e-07	191	172	8	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KLHL6 MYO1G PTCRA ENPP3 HLA-DRA NIBAN3 WDFY4 FCRL1	8.10e-07	191	172	8	47f20686001f945bc31d5a0b974958e4009edb34
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK PCDHB2 SVEP1 WDR93 CSPG4 AOC3 TENM1 DKK3	8.10e-07	191	172	8	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	VE-naiveBc\|VE / Condition, Cell_class and T cell subcluster	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	8.43e-07	192	172	8	87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1
ToppCell	VE-naiveBc-\|VE / Condition, Cell_class and T cell subcluster	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	8.43e-07	192	172	8	bca2aec4811627225fccd92abe2f3b1ba729c9ce
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.76e-07	193	172	8	7cc10e8b51091869d46e462f3214999e7b5348b1
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.76e-07	193	172	8	b5e44fe60dc84dc050d4fa3ccec4e257e51dc636
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.76e-07	193	172	8	e2cf2f4f142e1b4dda3ded28b5208eef3f301a43
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.76e-07	193	172	8	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C YY1AP1	8.76e-07	193	172	8	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	COVID-19_Severe-Lymphoid_B-B_intermediate\|COVID-19_Severe / Disease group, lineage and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.76e-07	193	172	8	ea079e6f7242a2bbc8260299ad9e9bdabb9856f8
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G HLA-DQA1 HLA-DRA NIBAN3 ADAM28 SLC2A3 FCRL1 TNFRSF13C	8.76e-07	193	172	8	8d88f3b0d08f9dbae26ee122dbd43f06e2cc3f67
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	8.76e-07	193	172	8	749faa5c592ee354733f5a7363a4277ef3462b93
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	7f62bd52779e2779447b23bdd330be4b5b35910a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	87604c93d20f9171e0a1279bdb6ad73fe5fed356
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	2b61023a602d336ed0de174e9141046173db34e6
ToppCell	COVID-19_Mild-Lymphoid_B-B_intermediate\|COVID-19_Mild / Disease group, lineage and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-B_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	9.11e-07	194	172	8	d4bbae30b9395139c745b71f8a4a356b11223b69
ToppCell	COVID-19_Severe-B_intermediate\|COVID-19_Severe / disease group, cell group and cell class	EPHB6 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	9.11e-07	194	172	8	3418308da7f1278ae2bf3fb61fc361b222e30043
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	9.11e-07	194	172	8	f2486b19ac52a48d19f80b38a5536bee3dad745b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCRA HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	9.11e-07	194	172	8	fb850d99bc1ce52c9ea8080199e6322902fd63a0
ToppCell	5'-Adult-LymphNode-Hematopoietic-B_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	9.47e-07	195	172	8	8f5dfcdaccb0c8318f90a33519a8d6d98ba22943
ToppCell	PBMC-Convalescent-Lymphocyte-B\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 UCHL1 TNFRSF13C	9.47e-07	195	172	8	07852aab50a2ece9938334301f0a9d7181da06b8
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABHD15 PTCRA HLA-DQA1 ENPP3 HLA-DRA IRF7 NIBAN3 WDFY4	9.47e-07	195	172	8	d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1	9.69e-07	135	172	7	7743a01dc9c4542e910e7c0fe046004692a680bf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCRA HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	9.84e-07	196	172	8	afd39d6d22d72d6b674a63d389a21f6dea6b9f20
ToppCell	10x5'-lymph-node_spleen\|World / Manually curated celltypes from each tissue	HLA-DQA1 HLA-DRA SLC44A2 NIBAN3 ADAM28 SLC2A3 FCRL1 TNFRSF13C	9.84e-07	196	172	8	2951be22ab9095c4d3286c69dc4ab3308287c145
ToppCell	PBMC-Convalescent-Lymphocyte-B\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 UCHL1 TNFRSF13C	9.84e-07	196	172	8	5e5928fc218859317860fc387928127ac8009ba8
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCRA HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	9.84e-07	196	172	8	cbccad6f554d5ec1ec22988f74362b5a69fc56d0
ToppCell	severe-Lymphocytic-B_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	1.02e-06	136	172	7	56a7b5c2e098b4a49124d1b905257a52eb38b519
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO1G PTCRA POLD1 HLA-DRA IRF7 CYP2S1 PKD1L3 NIBAN3	1.02e-06	197	172	8	59ddd8ff7dddf3747b988374e1a4d80959db803e
ToppCell	mild_COVID-19-B_intermediate\|mild_COVID-19 / disease group, cell group and cell class (v2)	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	1.02e-06	197	172	8	f669500120646f69355a6f920b892a6f2faeab63
ToppCell	Bronchus_Control_(B.)-Immune-TX-B_cells\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	HLA-DQA1 HLA-DRA NIBAN3 ADAM28 SLC2A3 PIKFYVE FCRL1 TNFRSF13C	1.06e-06	198	172	8	6231c44a909dd06f85c8210814e976a5f29148d0
ToppCell	MS-IIF-Lymphocyte-B-B_memory\|IIF / Disease, condition lineage and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A1 FCRL1 TNFRSF13C	1.06e-06	198	172	8	ae6f1d3ca7d7aa6f6f45b6b51aa8a967cadde017
ToppCell	Control-Lymphoid-Plasma,_B_cells\|Lymphoid / Condition, Lineage and Cell class	KLHL6 HLA-DQA1 HLA-DRA WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	1.06e-06	198	172	8	d2b7dd7919019dbfa18cfa52e64f4d27e56b9df6
ToppCell	severe-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	1.06e-06	198	172	8	88649dc642193bda5e8eff3f79c832807d5e200a
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 SLC2A3 FCRL1 TNFRSF13C	1.06e-06	198	172	8	824461cf44098440ba8bc0df96735423ac65bda1
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KLHL6 DBX2 HLA-DQA1 HLA-DRA CYP2S1 WDFY4 ADAM28 SLC2A1	1.06e-06	198	172	8	fa5c15a656d4132950092919600e270f1fd79abf
ToppCell	severe-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	1.10e-06	199	172	8	17283d75a2a900369f63ed02996e7ede97f46140
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory\|COVID-19_Severe / Disease, condition lineage and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	1.10e-06	199	172	8	24c05faa825c9d55279956469862440f9914a280
ToppCell	severe-B_memory\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TAS1R3 HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 FCRL1 TNFRSF13C	1.10e-06	199	172	8	6d3436dd65d525aaa23ec02672005380f21c4d0f
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate\|COVID-19_Severe / Disease, condition lineage and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	1.10e-06	199	172	8	ad3c369a67926725917b771094f82ca6dd2af783
ToppCell	mild-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	1.10e-06	199	172	8	e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate\|COVID-19_Mild / Disease, condition lineage and cell class	HLA-DQA1 HLA-DRA NIBAN3 WDFY4 ADAM28 PIKFYVE FCRL1 TNFRSF13C	1.10e-06	199	172	8	1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1
Drug	2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A	MARS1 NAGLU ADCK2 NCBP1 USP5 INTS5 RPAP1 SBF1 MAP3K11 MTRR	2.43e-06	195	172	10	1163_DN
Drug	14-F	TG ORM1 ORM2	4.19e-06	5	172	3	CID000079736
Disease	autoimmune thyroiditis (is_implicated_in)	HLA-DQA1 HLA-DRA TG	3.45e-05	12	162	3	DOID:7188 (is_implicated_in)
Disease	pemphigus vulgaris	HLA-DQA1 HLA-DRA THSD7B	8.63e-05	16	162	3	EFO_0004719
Disease	Anhydrotic Ectodermal Dysplasias	GJB6 BMS1	1.78e-04	4	162	2	C1706004
Disease	Henoch-Schoenlein purpura	HLA-DQA1 HLA-DRA MALRD1	2.32e-04	22	162	3	EFO_1000965
Disease	Noninfiltrating Intraductal Carcinoma	CA9 SLC2A1	2.96e-04	5	162	2	C0007124
Disease	Hidrotic Ectodermal Dysplasia	GJB6 BMS1	2.96e-04	5	162	2	C0162361
Disease	Atypical Ductal Breast Hyperplasia	CA9 SLC2A1	2.96e-04	5	162	2	C1332347
Disease	Ectodermal Dysplasia	GJB6 BMS1	4.43e-04	6	162	2	C0013575
Disease	EPILEPSY, CHILDHOOD ABSENCE, 1	SLC2A1 CACNA1H	4.43e-04	6	162	2	C1838604
Disease	serine protease inhibitor Kazal-type 2 measurement	ORM1 ORM2	4.43e-04	6	162	2	EFO_0802054
Disease	Aplasia Cutis Congenita	GJB6 BMS1	4.43e-04	6	162	2	C0282160
Disease	glycoprotein measurement	HGFAC HLA-DRA PKD1L3 ORM1 ORM2	5.17e-04	119	162	5	EFO_0004555
Disease	smoking status measurement, inflammatory bowel disease	HLA-DRA WDFY4	6.18e-04	7	162	2	EFO_0003767, EFO_0006527
Disease	perceived unattractiveness to mosquitos measurement	ACSL6 HLA-DQA1 HLA-DRA DHX8	6.74e-04	72	162	4	EFO_0008380
Disease	childhood absence epilepsy (is_implicated_in)	SLC2A1 CACNA1H	8.21e-04	8	162	2	DOID:1825 (is_implicated_in)
Disease	interleukin-21 measurement	HLA-DQA1 HLA-DRA	8.21e-04	8	162	2	EFO_0801724
Disease	oligoclonal band measurement	HLA-DQA1 HLA-DRA	8.21e-04	8	162	2	EFO_0005206
Disease	tyrosine-protein kinase receptor TYRO3 measurement	TYRO3 RPAP1	8.21e-04	8	162	2	EFO_0020829
Disease	Drug toxicity	ORM1 MTRR CACNA1H ABCC12	1.20e-03	84	162	4	C0013221
Disease	Adverse reaction to drug	ORM1 MTRR CACNA1H ABCC12	1.20e-03	84	162	4	C0041755
Disease	fish oil supplement exposure measurement, triglyceride measurement	GJB6 NCAN	1.31e-03	10	162	2	EFO_0004530, EFO_0600007
Disease	Disorders of Intracellular Cobalamin Metabolism	MTRR HCFC1	1.31e-03	10	162	2	cv:CN043592
Disease	lipid measurement, lipoprotein measurement	HGFAC HLA-DQA1 LLGL1 NCAN	1.55e-03	90	162	4	EFO_0004529, EFO_0004732
Disease	Ductal Carcinoma	CA9 SLC2A1	1.59e-03	11	162	2	C1176475
Disease	coagulation factor XA measurement	ORM1 ORM2	1.59e-03	11	162	2	EFO_0020266
Disease	thrombin generation potential measurement	GJB6 ORM1	1.59e-03	11	162	2	EFO_0005538
Disease	uveitis (implicated_via_orthology)	HLA-DQA1 AOC3	1.59e-03	11	162	2	DOID:13141 (implicated_via_orthology)
Disease	cataract (biomarker_via_orthology)	SLC2A14 SLC2A3	2.25e-03	13	162	2	DOID:83 (biomarker_via_orthology)
Disease	rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis	HLA-DQA1 HLA-DRA	2.25e-03	13	162	2	EFO_0000685, EFO_0006527, EFO_0009459
Disease	coagulation factor X measurement	ORM1 ORM2	2.25e-03	13	162	2	EFO_0020265
Disease	Myasthenia gravis	HLA-DQA1 SFMBT2	2.25e-03	13	162	2	EFO_0004991
Disease	smoking status measurement, ulcerative colitis	HLA-DRA WDFY4	2.25e-03	13	162	2	EFO_0000729, EFO_0006527
Disease	nodular sclerosis Hodgkin lymphoma	HLA-DQA1 HLA-DRA	2.61e-03	14	162	2	EFO_0004708
Disease	oligoclonal band measurement, multiple sclerosis	HLA-DQA1 HLA-DRA	2.61e-03	14	162	2	EFO_0005206, MONDO_0005301
Disease	familial hyperlipidemia	HGFAC HLA-DQA1 HLA-DRA SLC44A2	2.82e-03	106	162	4	MONDO_0001336
Disease	Body Weight	SEC16B WRAP53	3.00e-03	15	162	2	C0005910
Disease	allergic disease (is_implicated_in)	HLA-DQA1 HLA-DRA	3.00e-03	15	162	2	DOID:1205 (is_implicated_in)
Disease	myopia (is_implicated_in)	CPSF1 SLC39A5	3.42e-03	16	162	2	DOID:11830 (is_implicated_in)
Disease	Dermatitis	HLA-DQA1 SHARPIN	3.42e-03	16	162	2	C0011603
Disease	response to interferon-beta, anti-drug antibody measurement	HLA-DQA1 HLA-DRA	3.86e-03	17	162	2	EFO_0010559, GO_0035456
Disease	lymphocyte measurement	MYO1G CTU2 HLA-DQA1 HLA-DRA	4.01e-03	117	162	4	EFO_0803546
Disease	tropical spastic paraparesis	HLA-DQA1 HLA-DRA	4.33e-03	18	162	2	EFO_0007527
Disease	age at diagnosis, type 1 diabetes mellitus	HLA-DQA1 HLA-DRA USP31	4.85e-03	62	162	3	EFO_0004918, MONDO_0005147
Disease	seborrheic dermatitis	TNRC18 C1orf94	5.33e-03	20	162	2	EFO_1000764

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEAARPFLLTGPVCP	ADCK2	611	Q7Z695
VNLPLADLVFVCTLP	CXCR6	71	O00574
DPELLQFCRTPNPAL	CSPG4	2301	Q6UVK1
FNAPLPTDIISTPIC	ADAM28	396	Q9UKQ2
AALAPPVPPDCTLQL	ADGRA2	631	Q96PE1
PVPPDCTLQLLVFRN	ADGRA2	636	Q96PE1
DPPQKLPDLFSVLVC	ALG6	461	Q9Y672
SPAAPICFFPVVEAL	C9orf163	126	Q8N9P6
LSTCQFALPLLVPNP	GVINP1	991	Q7Z2Y8
FALPLLVPNPCTSQI	GVINP1	996	Q7Z2Y8
LEAQIPLCANLVPVP	ORM2	16	P19652
QDCPLRTPEDFVFPL	ARIH2	186	O95376
VEQELPSSPKQPICF	CEP76	76	Q8TAP6
ELAPCILAPPLVAGS	C1orf94	156	Q6P1W5
CPASLQEDPPILRQF	DENND1C	21	Q8IV53
AVSDISFLPDPCALP	BMS1	306	Q14692
QPNILICLVDNIFPP	HLA-DQA1	126	P01909
TFEIPPNLPCSVTLQ	ARRB1	116	P49407
LQTLCHFVLPVAPGP	ABHD15	106	Q6UXT9
QSPVDIRPQLAAFCP	CA9	161	Q16790
SCSFLLAPEDPIFPI	NAGLU	276	P54802
PSDNCVFSVELQLPP	AOC3	91	Q16853
CAFVAVPQRIPQPLL	CECR9	66	P0C854
VFPLNSRQDVICIPP	NWD1	1281	Q149M9
CLVISQPSPQASFLP	RFWD3	461	Q6PCD5
LVFPVFVQPLDLCNP	RGS3	551	P49796
PCPDPAPVQLIVQFL	INTS8	41	Q75QN2
GLCIFLPFVLSQLEP	NIBAN3	531	Q86XR2
TEPCVLPFQVLLENP	PCDHB2	101	Q9Y5E7
GFQPRVLVQCLPPAA	LLGL1	586	Q15334
ALLAPFPTQRVCSNP	HCFC1	1406	P51610
SLLLPLPFCGPNVLD	OR4D11	161	Q8NGI4
CPLNVPKVFNFDPLA	MBD6	66	Q96DN6
VCLVLDVAPPGLDSP	PTCRA	46	Q6ISU1
VPIVLISQLPFCGPN	OR11H6	176	Q8NGC7
EAPAFILPPRNLCIK	MYLK	31	Q15746
EADPLIRQCPEVFPL	KLHL6	276	Q8WZ60
LQDPFACVEALPAVP	MAGEL2	821	Q9UJ55
CSVNSQLEPCLPVFP	JMY	246	Q8N9B5
LDIVPPTFSALCPAN	NCBP1	466	Q09161
PAFIQTALPCPPCQV	NFXL1	621	Q6ZNB6
QPHPEDVLLFAIPIC	NEMF	986	O60524
PALLQCIVLPFCPES	SLC2A1	196	P11166
FPAAARELCVPLAVP	JMJD7	16	P0C870
PISLICEALAFPSPN	HMCN2	2566	Q8NDA2
PVFPAAKQCPALEVT	IL18BP	56	O95998
IPLISQCTPKVDFPQ	MDH2	206	P40926
PPPTVSELCALLVFL	DOP1B	471	Q9Y3R5
DLLLAFPSCQPPLSL	MTRR	426	Q9UBK8
NLEPCEPLPFDVARF	HERC1	2371	Q15751
LPFDCTQALAVPKPI	CPSF1	261	Q10570
TILQAFSLESPCPPD	CYP2S1	456	Q96SQ9
NKLIAPAVCFVIPPT	PPL	441	O60437
APFPCIPESQFLELQ	FAM205A	711	Q6ZU69
APFPCIPESQFLVLQ	FAM205BP	441	Q63HN1
SLFLPVIESVNPCLI	HERC4	696	Q5GLZ8
GECTNVLPIPFPSFL	MYADM	226	Q96S97
TLIFFPLPACLNPVL	LGR4	786	Q9BXB1
VCLLICNSPPYLLPA	MED25	141	Q71SY5
TPACLLPRNCDTPIF	IRF7	391	Q92985
QVTLFPRAGPPICLV	NHLRC4	71	P0CG21
ILPAILQSAALPCCP	SLC2A14	216	Q8TDB8
SLAPILPLQYICAPD	GREB1L	1761	Q9C091
ATRSQFVQPICLPEP	HGFAC	511	Q04756
LLVLFLAAFLPPPQC	OLFML1	11	Q6UWY5
LAAFLPPPQCTQDPA	OLFML1	16	Q6UWY5
VQFCLTIPPSAPPIA	MED14	1336	O60244
LCPERNPPTFFVAVL	SBF1	56	O95248
SLLLPLPFCGPNVLD	OR4D9	161	Q8NGE8
ICSIPDNLPFILKPT	PCDHB4	381	Q9Y5E5
CPLERFAELVGPVIP	ACP3	351	P15309
QEELAVPLPTGFCPL	MALRD1	1471	Q5VYJ5
PCVLPFQLLLEKPFQ	PCDHB7	101	Q9Y5E2
GLPCAFFAPVPESLL	PIKFYVE	966	Q9Y2I7
AFLPCEAVGNPLPTI	IGSF10	1666	Q6WRI0
PLELLCNVSGALPPA	IGSF8	321	Q969P0
LTFDFQQPVPLQPLC	PRMT7	581	Q9NVM4
QCPEGFDLPPVILFS	ENPP3	151	O14638
VPLKLCPAAEQVSPA	DBX2	81	Q6ZNG2
APLCEPAELFLIASP	FCRL1	11	Q96LA6
IDPCPNLVDCFISRP	GJB6	171	O95452
NFLFSPLPTPALICI	ACSL5	6	Q9ULC5
CQRPSTNELPLFDFP	DENND5A	271	Q6IQ26
EPNVLICFIDKFTPP	HLA-DRA	126	P01903
QDVPPSKCAQPVFLL	B3GNT3	96	Q9Y2A9
PALEFCIAVNPSILP	TMBIM6	101	P55061
LEAQIPLCANLVPVP	ORM1	16	P02763
ILQSAALPFCPESPR	SLC2A3	196	P11169
ALPFCPESPRFLLIN	SLC2A3	201	P11169
ASPLVLLEFQCPTPQ	SLC44A2	96	Q8IWA5
VFQVLPKCLSPETPL	ATRIP	586	Q8WXE1
CLALVPANTLPKAPL	DIP2A	891	Q14689
PPAESCASLQIPLAV	CACNA1H	1971	O95180
LCTSFAFLLPVANPP	SLC13A1	521	Q9BZW2
PSPPLSKDCIEQNFL	SLC38A9	416	Q8NBW4
AFQRGLLFPVCTPLP	DKK3	221	Q9UBP4
LLFPVCTPLPVEGEL	DKK3	226	Q9UBP4
FPEPERDPVIQICSL	POLD1	326	P28340
PPAPAQTEALSQLFC	CTU2	216	Q2VPK5
PPPCEVASFQELRLE	MAP3K11	106	Q16584
KELFPVLCQPDNPSV	DHX8	116	Q14562
FLLPACIFPSPGIED	DPPA2	261	Q7Z7J5
DVVLQSFPPLPSCEI	KIF23	471	Q02241
SFPPLPSCEILDIND	KIF23	476	Q02241
CPEAPILLHFPLVNA	PLA2G4D	721	Q86XP0
SLLLPLPFCGPNVLD	OR4D10	161	Q8NGI6
QPPACNVHFLSSLLP	TESMIN	116	Q9Y4I5
PQSPDTEALSCFLIP	NUTM2D	276	Q5VT03
PCPGLPAFAEVDLLS	TDRG1	31	Q3Y452
PEPVLSFLPQKDCTN	WRAP53	451	Q9BUR4
ANCFPPPVFIISISL	RHBDL2	66	Q9NX52
VPRDAPFQLETCPLT	TMEM161A	76	Q9NX61
FPRGAQPAPLLCSVL	LRRC41	596	Q15345
PQFCLPPVTQLAAVA	NTN5	26	Q8WTR8
PHLPANFEQVCVPLI	RIF1	351	Q5UIP0
PPAAQLPPVAFACID	RECQL4	591	O94761
ASNLAVVPPLLPLGC	TDRD10	346	Q5VZ19
SVLPQDPTQPCVHFL	SCRN2	291	Q96FV2
APDPCLVPLALEALV	NBEAL2	241	Q6ZNJ1
PPRDFDPALLEFLVC	PYURF	46	Q96I23
TPVALDFPCLDSPQA	EPHB6	941	O15197
ALPCLFTLQPRPSAA	NCAN	56	O14594
TLPLFPPIQASCLSD	PKD1L3	976	Q7Z443
DNIKAVFPCPSEPAL	POLR3A	926	O14802
EACFPPGPIRLQVTL	SHARPIN	211	Q9H0F6
CDISNFISPNPIVLP	TENM1	976	Q9UKZ4
PCDVFPVFLDLPVVT	PKHD1	76	P08F94
ICPFPSEALSPSQLL	INTS5	631	Q6P9B9
EVLDFCTLPQPVASP	SRCAP	1921	Q6ZRS2
PQVPACTGFFLSLLP	MRPL47	26	Q9HD33
PCPVPFVIPENALLS	SVEP1	3356	Q4LDE5
LFEAALFCPLPATIP	ABCC12	231	Q96J65
CLSRPNIFLCPEIEP	SMARCC2	136	Q8TAQ2
SPAAPLTPRQFALLC	SLC39A5	171	Q6ZMH5
AADDPFSPVCALPIQ	ABHD1	326	Q96SE0
KSPEPEFPSLVNLCQ	APOL5	41	Q9BWW9
APVPPQPDDLSIVCF	ACSL6	261	Q9UKU0
PQIPKSCPVFDIQLV	C12orf56	451	Q8IXR9
PTADPNSIPLVLCAD	CNOT6L	396	Q96LI5
TPLLSSEPPFLQLLC	RHBDD3	156	Q9Y3P4
LANQFPDISFCPALP	TBC1D24	121	Q9ULP9
PDISFCPALPAVVAL	TBC1D24	126	Q9ULP9
ARAPCLLLADVPFLP	VSX1	96	Q9NZR4
IQCAEPSPALLVPSA	TNRC18	2286	O15417
TICFLPPLVLNFELP	RNF14	66	Q9UBS8
LVCLSVLLFPGQPSP	TAS1R3	616	Q7RTX0
VLLFPGQPSPARCLA	TAS1R3	621	Q7RTX0
TFLAPSCQFPVLPQA	ROM1	51	Q03395
VILICFPNAPKVSPE	PPM1A	286	P35813
RLVLEFLNPAPPCGE	SLC5A10	486	A0PJK1
DNVPLLVPLFTDCTP	TMEM94	966	Q12767
CPNLFSPVLISENCP	SFMBT2	636	Q5VUG0
PEQSPCLLPGFRVLN	WDFY4	1691	Q6ZS81
VRPICLPFFDEELTP	TMPRSS4	306	Q9NRS4
PQIADAFAIPALCVV	XKR4	481	Q5GH76
ALATNQPVPLCLPAA	USF3	216	Q68DE3
QPVPLCLPAAISAQS	USF3	221	Q68DE3
VALLDAVPCLPALAP	TACC2	1051	O95359
DLLPPEVCSLLNPAA	NT5DC2	41	Q9H857
NPLSCVPALEAPPSL	RPAP1	856	Q9BWH6
VSFELCSNPGVLLPP	SEC16B	1006	Q96JE7
SFQEALRPIFSPCLP	TRIML1	436	Q8N9V2
IATLLVNPTSFPCPL	YY1AP1	636	Q9H869
PAVCFSSAPLLDLPA	VAX2	246	Q9UIW0
IICAFAPPGAFPLEV	WDR93	556	Q6P2C0
FLALQAALPAVPPDT	TCF23	96	Q7RTU1
TFDPFLCISLPIPLP	USP31	301	Q70CQ4
HFALQPPTEQACLIP	THSD7B	161	Q9C0I4
SCLLAPAPPSFILLL	nan	206	Q8N1Y9
PGNRTVDLFPVLPIC	TCTN3	76	Q6NUS6
PPLTPKFLNILDQVC	TUT7	991	Q5VYS8
PVLPPFCPLFASLVN	UBR2	876	Q8IWV8
PTPCVPAECFDLLVR	TNFRSF13C	16	Q96RJ3
NAPSFCPLVVLPSLT	TG	2071	P01266
LQLPPPACSILLTNF	MARS1	771	P56192
AGICPLNPFLVPLEL	SNAPC2	311	Q13487
FSLKQLDNPARIPPC	USP5	181	P45974
KDLAVPPNAPFQLSC	TYRO3	146	Q06418
FLCAFEIPVPVSPIS	USP32	991	Q8NFA0
LDLCPEPRTEFQPSF	ZNF169	81	Q14929
SVPAPACALLLLFPL	UCHL1	41	P09936
VLLPAVCAPTVPQFC	VWA5B1	161	Q5TIE3
ALAVRFLGCPPSIVP	ZBED4	1116	O75132
FVAPLPNPLAEFSAC	KLHL42	326	Q9P2K6
LPPAVLQPFQDTCHA	MYO1G	776	B0I1T2